This week, an AI system tested thousands of drug combinations for IPF and found one that could keep lung capacity nearly normal — a genuinely hopeful sign for people living with this disease.
FVC = how much air your lungs can push out. Higher % = healthier lungs. A typical IPF patient starts around 50–60%.
This is a computer model result — not a prescription. Always talk to your doctor before changing anything.
Researchers are working hard on IPF (a lung disease where scar tissue slowly replaces healthy lung). This week the database grew to nearly 6,700 studies and 1,708 real patient trials — more than ever before. Most new papers came from Russia and international preprint (early, not yet fully reviewed) servers, meaning scientists worldwide are sharing findings faster than ever.
The AI tested drug combinations and found a 7-drug mix that kept FVC (forced vital capacity — basically how much air your lungs can hold) at 98.3%. For comparison, healthy lungs score around 100%, so this result is remarkably close to normal. The drugs target scarring signals, lung cell repair, and inflammation all at once. These are still computer simulations, not proven treatments yet, but they point researchers toward the most promising real-world experiments to try next.
One question to ask your lung doctor at your next visit: 'Are there any clinical trials testing combination therapies — not just one drug — that I might qualify for right now?'